Loading...

Categories

26 Hyperglycemics Reports

North America Insulin Industry

Study Period: 2019 - 2029

Countries Covered: United States, Canada

Major Players: Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc, Biocon Limited

Insulin Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

APAC Insulin Market

Study Period: 2019 - 2029

Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Middle East and Africa Diabetes Treatment Market

Study Period: 2019- 2029

Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer

North America SGLT2 Inhibitors Market

Study Period: 2019 - 2029

Countries Covered: United States, Canada

Major Players: Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Astellas

Asia Pacific SGLT2 Inhibitors Market

Study Period: 2018 - 2029

Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

Europe Sodium-glucose Cotransporter 2 Market

Study Period: 2018 - 2029

Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia

Major Players: Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Eli Lilly and Company

Biguanides Market

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

MEA DPP-4 Inhibitors Market

Study Period: 2019- 2029

Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company

Meglitinides Market

Study Period: 2019- 2029

Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

North America Biguanides Market

Study Period: 2019- 2029

Countries Covered: United States, Canada

Major Players: Sanofi Aventis, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Merck & Co., Inc.

Sulfonylureas Industry

Study Period: 2019- 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Europe GLP 1 Receptor Agonist Industry

Study Period: 2019 - 2029

Countries Covered: United Kingdom, Germany, France, Italy, Spain, Russia

Major Players: Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca, Biocon

Fibrate Drugs Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma

North America Sulfonylureas Industry

Study Period: 2018 - 2029

Countries Covered: United States, Canada

Major Players: Mylan, Lupin, Merck and Co., Pfizer Inc., Sanofi Aventis

Glargine Insulin Market

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Latin America, Asia-Pacific, Middle East and Africa

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

APAC Biguanide Industry

Study Period: 2019 - 2029

Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

Latin America Biguanide Industry

Study Period: 2018 - 2029

Countries Covered: Mexico, Brazil

Major Players: Bristol-Myers Squibb, Boehringer Ingelheim, Merck and Co., Sanofi Aventis, Glenmark Pharmaceuticals

Latin America Human Insulin Drugs Industry

Study Period: 2019 - 2029

Countries Covered: Mexico, Brazil

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Pfizer

Latin America Meglitinide Industry

Study Period: 2018 - 2029

Countries Covered: Brazil, Mexico

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Europe Meglitinide Industry

Study Period: 2019 - 2029

Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

North America Meglitinide Industry

Study Period: 2018 - 2029

Countries Covered: United States, Canada

Major Players: Novo Nordisk, Glenmark, Novartis, KISSEI, Biocon

APAC Meglitinide Industry

Study Period: 2018 - 2029

Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Middle East And Africa Meglitinide Industry

Study Period: 2018 - 2029

Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Filter Reports

By Region

By Countries